Mereo BioPharma

Closed
Call
Website

Photos

800 Chesapeake Dr Ste 180
Redwood City, CA 94063
+1 (650) 995-8200
https://www.mereobiopharma.com
OncoMed Pharmaceuticals, founded in 2004, is a biotechnology company that deals in providing cancer treatment for individuals. The company conducts cancer stem cell research programs and has established a library of antibodies for the treatment of solid tumors, such as pancreatic, breast, colorectal and lung cancer. It is a privately owned company that receives funds from a group of investors, including US Venture Partners, Latterell Venture Partners(LVP), The Vertical Group, Morgenthaler Ventures, Nomura Phase4 Ventures Limited, Delphi Ventures, Adams Street Partners, De Novo Ventures and Bay Partners. OncoMed Pharmaceuticals OncoMed has established various technologies for the detection, isolation and characterization of tumor initiating cells. The company has tested more than 150 antibodies.

Also at this address

Own this business?
See a problem?

You might also like

Services, nec, nec, Business services, nec, nec, Real estate managers

Codexis, Inc

Codexis is one of the leaders in the development of innovative bio-based solutions for pharmaceutical chemical process development and manufacturing. The company s unique protein and strain engineering technology platform creates superior biological catalysts either enzymes or fermentation strains crafted specifically for cutting-edge chemical processes that can enable pharmaceutical process development, shorten process development timelines and dramatically improve existing manufacturing processes. Codexis has more than 12 strategic alliances, including a major collaboration with Pfizer, and more than 20 products and processes in development internally and at leading worldwide life sciences companies. It began operations as an independent company in 2002. Codexis is headquartered in Redwood City, Calif.
Genentech, Inc
Medical research, Real estate managers, Eating places

Genentech, Inc

Hoffmann-La Roche, also known as Roche, is prescription drug unit that provides more than 35 medications in the United States in therapeutic areas, including dermatology, oncology, transplantation, AIDS, central nervous system disorders, and cardiovascular and infectious diseases. It offers products that include Accutane, Boniva, CellCept, Copegus, Cytovene, Demadex EC-Naprosyn, Romazicon, Tamiflu, Ticlid, Valcyte, Valium, Xeloda, Xenical and Zenapax. The company operates over five research centers in New Jersey and California in the United States, as well as Switzerland, Germany and China. Hoffmann-La Roche works with a team of nearly 5,000 employees. It is a part of Roche Group, which is one of the world's leading research-oriented health care groups with core businesses in pharmaceuticals and diagnostics. Operational for more than 100 years, the parent company develops a range of products and services that address prevention, diagnosis and treatment of diseases.
Portola Pharmaceuticals
Business services, nec, nec, Services, nec, nec, Drugs and drug proprietaries

Portola Pharmaceuticals

Portola Pharmaceuticals is a Bay Area–based pharmaceuticals company with a focus on bioresearch and drug development. Their efforts are directed towards global markets, specifically in the treatment of cardiovascular disease and inflammation. Generated from their available business information
United States›California›Redwood City›Mereo BioPharma

Partial Data by Infogroup (c) 2025. All rights reserved.